Enterovirus A71 Live Attenuated Vaccines and Process for Producing the Same
Potential Commercialised
violet
Reg. ID : 17050
Comments
Description
The present invention discloses a live attenuated vaccine and a process for producing or producing the said live attenuated vaccine. The live attenuated vaccine is an Enterovirus A71 (EV-A71) live attenuated vaccine produced by codon deoptimization (CD) and codon-pair deoptimization (CPD) of EV-A71 viruses. In one specify embodiment, the EV-A71 live attenuated vaccine comprising CD chimera and CPD chimera of EV-A71viruses and the CD chimera and CPD chimera of EV-A71 viruses comprising synonymous mutations at the VP2, VP3, VP1 and 2A gene regions.
Contact Person/Inventor
| Name | Contact Phone | |
|---|---|---|
| Um Centre Of Innovation And Enterprise (Umcie) | umcie@um.edu.my | 013-2250151 / 03-79677351 |
Intellectual Property
| № | Type of IP | Registration ID |
|---|---|---|
| 1 | Patent Filed | PI 2013001189 |
Award
| Award Title | Award Achievement | Award Year Received |
|---|---|---|
| 0 | 0 | 0 |
-
Organisation Name
- UNIVERSITY OF MALAYAUNIVERSITI MALAYA50603KUALA LUMPUR
Comment